Bain Capital GSS Investment
Valuation each multiple against its own 5-year range
Vs. peers Shell Companies
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Bain Capital GSS Investment (BCSS) | 599.18M | 0.00 | 1.30 | 0.00% |
| Vylor Inc (VYLR) | 45.44B | 96.04 | 2.99 | 0.00% |
| DRUGS MADE IN AMERICA ACQ II CORP (DMII) | 651.65M | 27.65 | 1.30 | 0.00% |
| Churchill Capital Corp XI (CCXI) | 627.18M | 0.00 | 2.34 | 0.00% |
| EQV VENTURES ACQUISITION CORP. II (EVAC) | 609.61M | 35.97 | 1.31 | 0.00% |
| Cantor Equity Partners IV (CEPF) | 590.36M | 30.38 | 1.27 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 0.9% below Morningstar's fair value estimate.
Fair value
Bain Capital GSS Investment Corp is assigned a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a price consistent with our quantitative fair value estimate, which has a very high uncertainty rating.
The firm's valuation metrics strengthen our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 76.5%, which falls in the top 45% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our balanced fair value estimate.
Alternatively, the firm's unfavorable dividend structure is potentially concerning. Dividends represent a stable form of future cash flows returned to shareholders, and low dividend payments can increase the perceived risk of a business. The firm's forward dividend yield of 0%, for example, falls in the bottom 30% compared with global peers. This could imply a planned dividend cut or relatively high share price, which further promotes our neutral price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is fairly-valued, this outperformance had a negative impact on our valuation estimate.
Economic moat
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.
By Quantitative Equity Report
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Bain Capital GSS Investment discussion 0 comments